Earnings Labs
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE) Earnings

NASDAQ·Healthcare·Biotechnology

$24.54

+2.29%

Mkt Cap $2.37B

Next Earnings

In 6 days

Tue, May 5, 2026

EPS Estimate

-$1.53

9 analysts

Revenue Estimate

$159.32M

Last quarter: missed by -7.50% on EPS, +4.23% on revenue.

RARE reports 2026-05-05 earnings on Tuesday, May 5, 2026 (6 days from today). Consensus estimates are EPS -$1.53 and revenue $159.32M.

Last quarter, RARE missed EPS estimates by 7.5% on revenue of $207.00M.

View RARE earnings dates & history

EPS — Estimate vs Actual

Mkt Cap

$2.37B

P/E

Fwd P/E

P/S

3.52

Rev TTM

EPS TTM

-$5.84